insights_auto
Why is RGEN up 4.27%?
Dive Deeperchevron_right
RGEN:NASDAQ
Repligen Corp
$184.80
arrow_upward
+4.27%(+7.57) 1D
Oct 2, 10:24:29 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for RGEN...
Open
$179.32
High
$185.36
Low
$178.00
Mkt. cap
10.46B
Avg. vol.
1.08M
Volume
137.42K
P/E ratio
252.67
52-wk high
$198.86
52-wk low
$100.99
EPS
$0.73
Beta
1.08
Shares outstanding
56.44M
No. of employees
2K
Open
$179.32
High
$185.36
Low
$178.00
Mkt. cap
10.46B
Avg. vol.
1.08M
Volume
137.42K
P/E ratio
252.67
52-wk high
$198.86
52-wk low
$100.99
EPS
$0.73
Beta
1.08
Shares outstanding
56.44M
No. of employees
2K
News stories
From web sources and news partners
GuruFocus
·
15 hours ago
A Look at Repligen Corp (RGEN) After 7.8% Decline -- GF Value $179.80 vs Price $177.23
Simply Wall Street
·
16 hours ago
Repligen (RGEN) Stock Looks Stretched After A 32% One Year Run
Investing.com
·
3 days ago
Repligen stock price target reaffirmed at $225 by UBS on growth outlook
Stocktwits
·
3 days ago
Why Did KOD, RGEN, BIIB Stocks Rise To 52-Week Highs?
Profile
Repligen Corporation is an American life sciences company that develops and manufactures products used in biological drug manufacturing. The company is headquartered in Waltham, Massachusetts, and is listed on the Nasdaq under the symbol RGEN. Wikipedia
About Repligen Corp
CEOTony J. Hunt
Employees2K
Founded1981
HeadquartersWaltham, Massachusetts, United States
SectorHealth care
Websiterepligen.com